Fresenius Medical Care Completes Acquisition of NxStage Medical
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Company Presents 17 Abstracts Highlighting Commitment to Improving Patient Outcomes and Promise of Remote Monitoring for Home Dialysis Patients
WALTHAM, Mass. – May 9, 2019 – Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, headquartered in Waltham, Mass., welcomes the National Kidney Foundation (NKF) Spring Clinical Meetings to Boston. The company is presenting 17 abstracts and posters highlighting efforts to improve patient outcomes, including a retrospective analysis that suggests home peritoneal dialysis (PD) patients who are remotely monitored by a connected Liberty Cycler machine stay on the modality longer, have higher transplantation rates and lower mortality rates.
“We are pleased to welcome this important clinical meeting by the National Kidney Foundation to our company’s hometown,” said Bill Valle, CEO of FMCNA. “Our many presentations at the NKF Spring Clinical Meetings reinforce our commitment to driving vital industry research to ensure the highest quality of care possible for people living with kidney disease.”
For more than 25 years, nephrology healthcare professionals from across the country have come to the NKF Spring Clinical Meetings to learn about the newest developments related to all aspects of clinical nephrology and to present their research findings. It is being held this year from May 8-12 at the Hynes Convention Center in Boston.
In a poster presentation titled “Remote Patient Monitoring (RPM) and Longevity on Peritoneal Dialysis (PD),” data from 714 patients using remote monitoring with the Liberty Cycler was compared to 12,032 patients using standard communication between 2012-2017. The retrospective analysis shows that patients who used remote monitoring stayed on PD an average of 44 days longer, had an 11 percent lower rate of stopping PD and a 19 percent higher rate of transplantation.
“Our research continues to demonstrate the benefits of connected health platforms for our home dialysis machines, including the Liberty Cycler and NxStage System One,” said Dr. Robert Kossmann, Chief Medical Officer for FMCNA. “We are committed to furthering innovation around connected health technologies to ensure home dialysis is even better and easier for our patients.”
Highlights of FMCNA poster presentations and abstracts at the 2019 NKF Spring Clinical Meeting include:
More information about the NKF Spring Clinical Meetings can be found here: kidney.org/spring-clinical
About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.